![肿瘤药物治疗方案及综合评价](https://wfqqreader-1252317822.image.myqcloud.com/cover/13/43604013/b_43604013.jpg)
上QQ阅读APP看本书,新人免费读10天
设备和账号都新为新人
第四章 鼻咽癌
局部晚期鼻咽癌诱导化疗
方案Ⅰ TPF+ CCRT vs CCRT
![](https://epubservercos.yuewen.com/B8A9D8/22919013101368106/epubprivate/OEBPS/Images/T32_280_1268_2033_2057_147306.jpg?sign=1738852475-RfCLtKBisrnA0wdETXflgxcKoiYQtoiA-0-3a53f1144a830317c74dd618910b001b)
方案评价
![](https://epubservercos.yuewen.com/B8A9D8/22919013101368106/epubprivate/OEBPS/Images/T32_280_2141_2020_2844_147307.jpg?sign=1738852475-hnxSwcxelVl3vsrtPr57agOquQuuQJxI-0-963b238f62d498760512c74a8c95e5cb)
续表
![](https://epubservercos.yuewen.com/B8A9D8/22919013101368106/epubprivate/OEBPS/Images/T33_236_339_1984_2057_147309.jpg?sign=1738852475-fjgp52HdGO1C44gPJGNEeCCJqWgMFNqm-0-899404ccaa168071a10bc707e80c061b)
点评
本方案来源于Ⅲ期多中心随机对照试验,研究结果显示:在局部晚期鼻咽癌(Ⅲ~ⅣB期,除外T3~4N0),与单纯同步放化疗相比,3周期TPF诱导化疗能显著改善局部晚期鼻咽癌的无失败生存,且毒性可控。该研究为诱导化疗+同步放化疗的治疗模式提供了理论基础。
(彭星辰 谢钰鑫)
参考文献
[1] SUN Y,LI W-F,CHEN N-Y,et al.Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma:a phase 3,multicentre,randomised controlled trial.Lancet Oncol,2016,17:1509-1520.